WO2007052001A2 - Production process of ortho-substituted benzoic acid derivatives usin 4-(2-carboxybenzyloxy or thio)-phenylacetic acid as key intermediate - Google Patents
Production process of ortho-substituted benzoic acid derivatives usin 4-(2-carboxybenzyloxy or thio)-phenylacetic acid as key intermediate Download PDFInfo
- Publication number
- WO2007052001A2 WO2007052001A2 PCT/GB2006/004044 GB2006004044W WO2007052001A2 WO 2007052001 A2 WO2007052001 A2 WO 2007052001A2 GB 2006004044 W GB2006004044 W GB 2006004044W WO 2007052001 A2 WO2007052001 A2 WO 2007052001A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- formula
- optionally
- fluoro
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 0 C*1C=CC(CN(*)C(C*c2ccc(*CC3=CCCC=C3C(O)=O)cc2)=O)=CC=C1 Chemical compound C*1C=CC(CN(*)C(C*c2ccc(*CC3=CCCC=C3C(O)=O)cc2)=O)=CC=C1 0.000 description 4
- BXHJLEYNPYHART-UHFFFAOYSA-N OC(Cc(cc1)ccc1SCc1ccccc1C(O)=O)=O Chemical compound OC(Cc(cc1)ccc1SCc1ccccc1C(O)=O)=O BXHJLEYNPYHART-UHFFFAOYSA-N 0.000 description 3
- WNZQDUSMALZDQF-UHFFFAOYSA-N O=C1OCc2ccccc12 Chemical compound O=C1OCc2ccccc12 WNZQDUSMALZDQF-UHFFFAOYSA-N 0.000 description 2
- JAKZWXDRSYMKGG-UHFFFAOYSA-N OC(CC(CC1)=CC=C1S)=O Chemical compound OC(CC(CC1)=CC=C1S)=O JAKZWXDRSYMKGG-UHFFFAOYSA-N 0.000 description 1
- YFAMLLATCWYORZ-UHFFFAOYSA-N OC(CC1C=CC(S)=CC1)=O Chemical compound OC(CC1C=CC(S)=CC1)=O YFAMLLATCWYORZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
- C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
Definitions
- the present invention relates to processes for preparing certain benzoic acid derivatives that have utility in treating clinical conditions associated with insulin resistance and to novel intermediates used in this process.
- R 1 represents halo, a C 1-4 alkyl group which is optionally substituted by one or more fluoro, a Ci -4 alkoxy group which is optionally substituted by one or more fluoro and wherein when n is 2 the substituents R 1 may be the same or different;
- R 2 represents a C 2-8 alkyl group which is optionally interrupted by oxygen;
- Y is absent or represents methylene; and X is O or S; and pharmaceutically acceptable salts and prodrugs thereof have utility in treating clinical conditions associated with insulin resistance.
- R 1 , R 2 , X and Y are as previously defined and PG represents a protecting group for a carboxylic hydroxy group as described in the standard text "Protective Groups in
- a leaving group for example halo, e.g. bromo
- solvent for example acetonitrile
- a base for example potassium carbonate
- the present invention provides a process for the preparation of a compound of formula I
- Y is absent or represents methylene
- X is O or S or a salt thereof optionally in the presence of a base and optionally in the presence of an inert solvent, at a temperature in the range of 0 to 15O 0 C.
- the present invention provides a process for the preparation of a compound of formula IA
- the intermediate has the advantage of being a crystalline material that can be easily purified by recrystallisation and this results in an increase in purity of the final product.
- chromatography had to be used to purify intermediate oils.
- new processes reduce the use of toxic chemicals eg N-bromosuccinimide.
- the present invention provides a process for the preparation of a compound of formula V
- R 1 represents halo, a C 1-4 alkyl group which is optionally substituted by one or more fluoro, a group which is optionally substituted by one or more fluoro and wherein when n is 2 the substituents R 1 may be the same or different, R 2 represents a C 2-8 alkyl group which is optionally interrupted by oxygen, Y is absent or represents methylene and X is O or S , which comprises reacting a compound of formula I
- R 1 represents halo, a Ci -4 alkyl group which is optionally substituted by one or more fluoro, a C 1-4 alkoxy group which is optionally substituted by one or more fluoro and wherein when n is 2 the substituents R 1 may be the same or different, R 2 represents a C 2-8 alkyl group which is optionally interrupted by oxygen, optionally in the presence of a coupling agent and optionally in the presence of solvent, for example tetrahydrofuran or acetonitrile at a temperature in the range of -100°C to 150°C.
- the present invention provides a process for the preparation of a compound of formula VA
- a coupling agent for example 1,1-carbonyl diimidazole and optionally in the presence of solvent, for example tetrahydrofuran, at a temperature in the range ofO to l50°C.
- This process may also be performed using a salt of the compound of formula IV and generating the free amine in situ by reaction with a base for example triethylamine or sodium hydroxide .
- a base for example triethylamine or sodium hydroxide .
- the present invention provides a process for the preparation of a compound of formula V
- R 1 represents halo, a Ci -4 alkyl group which is optionally substituted by one or more fluoro, a C ⁇ alkoxy group which is optionally substituted by one or more fluoro and wherein when n is 2 the substituents R 1 may be the same or different, R 2 represents a C 2- salkyl group which is optionally interrupted by oxygen,
- Y is absent or represents methylene and X is O or S , which comprises a) reacting a compound of formula II
- Y is absent or represents methylene and X is O or S or a salt thereof optionally in the presence of a base for example sodium ethoxide and optionally in the presence of solvent, for example ethanol, at a temperature in the range of 0 to 150°C to give a compound of formula I
- R 1 represents halo, a C 1-4 alkyl group which is optionally substituted by one or more fluoro, a Ci. 4 alkoxy group which is optionally substituted by one or more fluoro and wherein when n is 2 the substituents R 1 may be the same or different
- R 2 represents a C 2-8 alkyl group which is optionally interrupted by oxygen
- n is 0, 1 or 2 and R 1 represents halo, a C 1-4 alkyl group which is optionally substituted by one or more fluoro, a C ⁇ all-oxy group which is optionally substituted by one or more fluoro and wherein when n is 2 the substituents R 1 may be the same or different
- R 2 represents a C 2-8 alkyl group which is optionally interrupted by oxygen, optionally in the presence of a coupling agent and optionally in the presence of solvent, for example tetrahydrofuran, at a temperature in the range of 0 to 150°C .
- This process may also be performed using a salt of the compound of formula IV and generating the free amine in situ by reaction with a base for example optionally in the presence of a base for example sodium ethoxide
- the present invention provides a process for the preparation of a compound of formula VA
- IVA optionally in the presence of a coupling agent for example a 1,1-carbonyl diimidazole and optionally in the presence of solvent, for example tetrahydrofuran, at a temperature in the range of 0 to 150°C and optionally step c)
- a coupling agent for example a 1,1-carbonyl diimidazole
- solvent for example tetrahydrofuran
- R 2 NH 2 VII in an inert solvent for example toluene and then reducing the imine obtained for example by catalytic hydrogenation e.g under pressure or by use of a hydride e.g sodium borohydride.
- an inert solvent for example toluene
- reducing the imine obtained for example by catalytic hydrogenation e.g under pressure or by use of a hydride e.g sodium borohydride.
- Suitable bases include a carbonate base (e.g sodium carbonate or potassium carbonate optionally in a finely divided state e.g. 235 mesh), an alkali metal C 1-4 alkoxide (e.g. sodium methoxide, lithium methoxide, potassium methoxide, sodium ethoxide, lithium ethoxide, potassium ethoxide, sodium propoxide, lithium propoxide, potassium propoxide, sodium ⁇ opropoxide, lithium ⁇ propoxide, potassium wopropoxide, sodium tert- butoxide, lithium fert-butoxide or potassium f ⁇ rt-butoxide), an alkali metal hydroxide (e.g.
- a carbonate base e.g sodium carbonate or potassium carbonate optionally in a finely divided state e.g. 235 mesh
- an alkali metal C 1-4 alkoxide e.g. sodium methoxide, lithium methoxide, potassium methoxide, sodium ethoxide, lithium e
- LDA lithium diisopropylamide
- LiHMDS lithium (bistrimethylsilylamide
- inert solvent refers to a solvent that does not react with the starting materials, reagents, intermediates or products in a manner that adversely affects the yield of the desired product.
- Suitable inert solvents include Cj -4 alkanol (e.g.methanol, ethanol, propanol w ⁇ propanol, tert-butanol), acetonitrile, N-methylpyrrolidin-2-one ( ⁇ MP), dimethylsulfoxide (DMSO), N,N-dimethylformamide (DMF), N,N-dimethylacetamide (DMA), tetrahydrofuran (THF), methyl tert-butyl ether (MTBE) or 1,2-dimethoxyethane (DME).
- Cj -4 alkanol e.g.methanol, ethanol, propanol w ⁇ propanol, tert-butanol
- acetonitrile e.g.methanol, ethanol, prop
- Suitable coupling agents include 1,1-carbonyl diimidazole, a carbodiimide (e.g. (l-(3- dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI) or dicyclohexyl- carbodiimide (DCCI)), O-[(Ethoxycarbonyl)-cyanomethyleneammo]-N,N,N,N- tetramethyluronium BF4 (TBTU), O-(benzotriazol-l-yl)-N,N,N' ) N'-tetramethyluronium hexafluorophosphate (HBTU), 0-(7-azabenzotriazol-l -y ⁇ )-N,NJF ,iV-tetramethyluronium hexafluorophosphate (HATU), isobutylchloroformate and thionyl chloride.
- a particular coupling agent is 1,1 -carbon
- Tetrahydrofuran (200ml) was added, followed by 37% hydrochloric acid (38.6 ml) and sodium chloride (72.6g). The aqueous phase was discarded. The organic phase was distilled, further tetrahydrofuran (4x200ml) was added and the distillation continued until the batch was dry. Acetonitrile (510ml) was added and the distillation continued until the tetrahydrofuran has been distilled out. (4- ⁇ [2- (carboxy)benzyl]thio ⁇ phenyl)acetic acid crystallised out during the solvent exchange. The resultant slurry was cooled to 22°C and the product isolated by filtration, washed with acetonitrile and dried in a vacuum oven at 40°C.
- the process to prepare this compound forms part of the present invention that is a process wherein the Q compound of formula VA is reacted with 2-methylpropan-2-amine in an inert solvent at a temperature in the range of 0 0 C to 100 0 C to give 2-( ⁇ [4-(2- ⁇ ethyl[4- (trifluoromethyl)benzyl]amino ⁇ -2-oxoethyl)phenyl]thio ⁇ methyl)benzoic acid 2- methylpropan-2-amine salt (1:1) .
- Ethylamine hydrochloride 42.8g,1.23 equivalents
- 4-trifluoromethyl benzaldehyde 75.3g, 1.00 equivalent
- toluene 188.4mL,2.55 volumes
- 4M sodium hydroxide solution 129.8 mL,1.23 equivalents
- the mixture was held at ambient temperature until the reaction to the imine was complete.
- the biphasic liquor was separated. Water (18.2 mL) was added to the toluene phase and this imine liquor was hydrogenated with 5% Palladium on carbon (73.8mg -weight of palladium employed) as catalyst under a head of hydrogen of 200 kpascals (1 BarG) .
- the hydrogenated liquor was screened to remove catalyst, separated, washed with water and evaporated to give N-ethyl-4-trifluoromethylbenzylamine.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A process for the preparation of a compound of formula (I) in which Y is absent or represents methylene, and X is O or S which comprises reacting a compound of formula (II) with a compound of formula (III) in which Y is absent or represents methylene, and X is O or S or a salt thereof optionally in the presence of a base and optionally in the presence of an inert solvent, at a temperature in the range of 0 to 150°C and reaction of the compound of formula (I) with a compound of formula (IV) to give a compound of formula (V) or a salt thereof.
Description
CHEMICAL PROCESS
The present invention relates to processes for preparing certain benzoic acid derivatives that have utility in treating clinical conditions associated with insulin resistance and to novel intermediates used in this process.
WO 2004/000790 (PCT/GB02/05743) discloses compounds of formula A
Y is absent or represents methylene; and X is O or S; and pharmaceutically acceptable salts and prodrugs thereof have utility in treating clinical conditions associated with insulin resistance.
In this application processes for the preparation of compounds of formula A are described as follows. Compounds of formula A may be prepared by reacting a compound of formula
II
,nd
Organic Synthesis", 2 Edition (1991) by Greene and Wuts, with a de-protecting agent.
Compounds of formula II may be prepared by reacting a compound of formula III
V in which R1, n, R2 , X and Y are as previously defined with a compound of formula VI
Vl in which PG is as previously defined and L represents a leaving group, for example halo, e.g. bromo, optionally in the presence of solvent, for example acetonitrile, and optionally in the presence of a base, for example potassium carbonate, at a temperature in the range of 0 to 150°C.
J. Med. Chem. 1977, Vol. 20, p66-70 describes the preparation of (4-{[2- (carboxy)benzyl]thio}phenyl)acetic acid in 32% yield from ethyl 4-mercaptophenyl acetate and ethyl 2-bromomethylbenzoate. The (4-{[2-(carboxy)benzyl]thio}phenyl)acetic acid obtained was used in the synthesis of a dibenz[ b,e]thiepina-acetic acid.
A new process has now been found that reduces the problems encountered in these previously described processes.
The present invention provides a process for the preparation of a compound of formula I
in which Y is absent or represents methylene, and X is O or S which comprises reacting a compound of formula II
in which Y is absent or represents methylene, and X is O or S or a salt thereof optionally in the presence of a base and optionally in the presence of an inert solvent, at a temperature in the range of 0 to 15O0C.
When a base is used the compound of formula I is isolated after acidification of the reaction mixture.
In particular the present invention provides a process for the preparation of a compound of formula IA
IA which comprises reacting a compound of formula II
or a salt thereof optionally in the presence of a base and optionally in the presence of an inert solvent, for example ethanol, at a temperature in the range of 0 to 150°C. These processes provides a considerable saving in cost over previously described processes as they employ commercially available starting materials and use fewer steps. The intermediate has the advantage of being a crystalline material that can be easily purified by recrystallisation and this results in an increase in purity of the final product. In previous processes chromatography had to be used to purify intermediate oils. In addition the new processes reduce the use of toxic chemicals eg N-bromosuccinimide.
In another aspect the present invention provides a process for the preparation of a compound of formula V
V wherein n is 0, 1 or 2 and R1 represents halo, a C1-4alkyl group which is optionally substituted by one or more fluoro, a
group which is optionally substituted by one or more fluoro and wherein when n is 2 the substituents R1 may be the same or different, R2 represents a C2-8alkyl group which is optionally interrupted by oxygen, Y is absent or represents methylene and X is O or S , which comprises reacting a compound of formula I
I wherein Y is absent or represents methylene and X is O or S with a compound of formula IV
IV wherein n is 0, 1 or 2 and R1 represents halo, a Ci-4alkyl group which is optionally substituted by one or more fluoro, a C1-4alkoxy group which is optionally substituted by one or more fluoro and wherein when n is 2 the substituents R1 may be the same or different, R2 represents a C2-8alkyl group which is optionally interrupted by oxygen, optionally in the presence of a coupling agent and optionally in the presence of solvent, for example tetrahydrofuran or acetonitrile at a temperature in the range of -100°C to 150°C.
In another aspect the present invention provides a process for the preparation of a compound of formula VA
VA
which comprises reacting a compound of formula I A
IA with a compound of formula IVA
IVA
optionally in the presence of a coupling agent for example 1,1-carbonyl diimidazole and optionally in the presence of solvent, for example tetrahydrofuran, at a temperature in the range ofO to l50°C.
This process may also be performed using a salt of the compound of formula IV and generating the free amine in situ by reaction with a base for example triethylamine or sodium hydroxide .
In another aspect the present invention provides a process for the preparation of a compound of formula V
V
wherein n is 0, 1 or 2 and R1 represents halo, a Ci-4alkyl group which is optionally substituted by one or more fluoro, a C^alkoxy group which is optionally substituted by one or more fluoro and wherein when n is 2 the substituents R1 may be the same or different, R2 represents a C2-salkyl group which is optionally interrupted by oxygen,
Y is absent or represents methylene and X is O or S , which comprises a) reacting a compound of formula II
with a compound of formula III
wherein Y is absent or represents methylene and X is O or S or a salt thereof optionally in the presence of a base for example sodium ethoxide and optionally in the presence of solvent, for example ethanol, at a temperature in the range of 0 to 150°C to give a compound of formula I
b) reacting the compound of formula I with a compound of formula IV
wherein n is 0, 1 or 2 and R1 represents halo, a C1-4alkyl group which is optionally substituted by one or more fluoro, a Ci.4alkoxy group which is optionally substituted by one or more fluoro and wherein when n is 2 the substituents R1 may be the same or different, R2 represents a C2-8alkyl group which is optionally interrupted by oxygen, wherein n is 0, 1 or 2 and R1 represents halo, a C1-4alkyl group which is optionally substituted by one or more fluoro, a C^all-oxy group which is optionally substituted by one or more fluoro and wherein when n is 2 the substituents R1 may be the same or different, R2 represents a C2-8alkyl group which is optionally interrupted by oxygen, optionally in the presence of a coupling agent and optionally in the presence of solvent, for example tetrahydrofuran, at a temperature in the range of 0 to 150°C .
This process may also be performed using a salt of the compound of formula IV and generating the free amine in situ by reaction with a base for example optionally in the presence of a base for example sodium ethoxide
In another aspect the present invention provides a process for the preparation of a compound of formula VA
with a compound of formula IIIA
UIA
or a salt thereof optionally in the presence of a base for example sodium ethoxide and optionally in the presence of solvent, for example ethanol, at a temperature in the range of 0 to 150°C to give a compound of formula IA
IA
and then
b) reacting the compound of formula IA with a compound of formula IVA
IVA optionally in the presence of a coupling agent for example a 1,1-carbonyl diimidazole and optionally in the presence of solvent, for example tetrahydrofuran, at a temperature in the range of 0 to 150°C and optionally step c)
c) reacting a compound of formula VA
with 2-methylpropan-2-amine (t-butylamine) in a diluent ( for example acetonitrile) at a temperature in the range of 0 to 100°C to give 2-({[4-(2-{ethyl[4-(trifluoromethyl)benzyl]- amino}-2-oxoethyl)phenyl]thio}methyl)benzoic acid 2-methylpropan-2-amine salt (1:1). Compounds of formula IV may be prepared by reacting a compound of formula VI
Vl
with a compound of formula VII
R2NH2 VII
in an inert solvent for example toluene and then reducing the imine obtained for example by catalytic hydrogenation e.g under pressure or by use of a hydride e.g sodium borohydride.
Compounds of formula IVA may be prepared by reacting a compound of formula VIA
with a compound of formula VIIA
EtNH2 VIIA
in an inert solvent for example toluene and then reducing the imine obtained for example by catalytic hydrogenation e.g. under pressure.
Suitable bases include a carbonate base ( e.g sodium carbonate or potassium carbonate optionally in a finely divided state e.g. 235 mesh), an alkali metal C1-4 alkoxide (e.g. sodium methoxide, lithium methoxide, potassium methoxide, sodium ethoxide, lithium ethoxide, potassium ethoxide, sodium propoxide, lithium propoxide, potassium propoxide, sodium ώopropoxide, lithium ώøpropoxide, potassium wopropoxide, sodium tert- butoxide, lithium fert-butoxide or potassium ført-butoxide), an alkali metal hydroxide (e.g. sodium hydroxide, lithium hydroxide or potassium methoxide), an alkali metal hydride (for example sodium hydride) or a base such as lithium diisopropylamide (LDA) or lithium (bistrimethylsilylamide (LiHMDS). A particular base is sodium ethoxide.
The expression "inert solvent" refers to a solvent that does not react with the starting materials, reagents, intermediates or products in a manner that adversely affects the yield of the desired product. Suitable inert solvents include Cj-4 alkanol (e.g.methanol, ethanol, propanol wøpropanol, tert-butanol), acetonitrile, N-methylpyrrolidin-2-one (ΝMP), dimethylsulfoxide (DMSO), N,N-dimethylformamide (DMF), N,N-dimethylacetamide (DMA), tetrahydrofuran (THF), methyl tert-butyl ether (MTBE) or 1,2-dimethoxyethane (DME).
Suitable coupling agents include 1,1-carbonyl diimidazole, a carbodiimide (e.g. (l-(3- dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI) or dicyclohexyl- carbodiimide (DCCI)), O-[(Ethoxycarbonyl)-cyanomethyleneammo]-N,N,N,N- tetramethyluronium BF4 (TBTU), O-(benzotriazol-l-yl)-N,N,N')N'-tetramethyluronium hexafluorophosphate (HBTU), 0-(7-azabenzotriazol-l -yϊ)-N,NJF ,iV-tetramethyluronium hexafluorophosphate (HATU), isobutylchloroformate and thionyl chloride. A particular coupling agent is 1,1 -carbonyl diimidazole.
Examples Example 1
A mixture of 4-mercaptophenylacetic acid (40.4Og) and ethanol (395g) was degassed and then a degassed solution of sodium ethoxide in ethanol (152g of a 21% w/w solution) was added. The mixture was again degassed and then phthalide (31.92g) was added and the reaction mixture was boiled under reflux for 5 days. The thick slurry was distilled under nitrogen, then degassed water (300ml) was added and distillation continued until the reaction solvent had been changed from ethanol to water. The clear solution was cooled to 22°C and extracted with ethyl acetate (2x100ml). After screening through a filtration aid (harborlite), the ethyl acetate phase was discarded. Tetrahydrofuran (200ml) was added, followed by 37% hydrochloric acid (38.6 ml) and sodium chloride (72.6g). The aqueous phase was discarded. The organic phase was distilled, further tetrahydrofuran (4x200ml) was added and the distillation continued until the batch was dry. Acetonitrile (510ml) was added and the distillation continued until the tetrahydrofuran has been distilled out. (4-{[2- (carboxy)benzyl]thio}phenyl)acetic acid crystallised out during the solvent exchange. The resultant slurry was cooled to 22°C and the product isolated by filtration, washed with acetonitrile and dried in a vacuum oven at 40°C. Example 2
(4-{[2-(Carboxy)benzyl]thio}phenyl)acetic acid (15.0g) was dissolved in degassed THF (150ml). The solution was distilled under nitrogen to remove water by collecting approximately 75 ml of THF as distillate. Meanwhile 1,1-carbonyl di-imidazole (CDI) (16.32g) was added to THF (105ml) with stirring under nitrogen to form a slurry. The solution of the acid was added to the stirred CDI slurry under nitrogen at such a rate as to control the rate of evolution of liberated carbon dioxide (approximately 2 hours) as l-[(4-
{2-(lH-imidazol-l-ylcarbonyl)benzyl]thio}phenylacetyl]-lH-imidazole was formed. A solution of N-ethyl-[4-(trifluoromethyl)benzyl]amine (11.17g) in TΗF (15ml) was added over 2 hours at 22°C. After stirring for 3 hours the TΗF solution containing N-ethyl-2-(4- {[2-(lH-imidazol-l-ylcarbonyl)benzyl]thio}phenyl)-N-[4-(trifluoromethyl)benzyl]-
5 acetamide was slowly added to 2M hydrochloric acid ( 94.3ml) with stirring under nitrogen over approximately 4 hours. After overnight stirring sodium chloride (19.2g) was added to saturate the aqueous phase. The aqueous phase was then separated off. The TΗF layer was evaporated on a rotary evaporator. The resultant oil was dissolved in methyl tert-butyl ether (MTBE) (60ml) and water (105ml ) added followed by 2M sodium Q hydroxide (30.6ml). The MTBE layer was discarded. Fresh MTBE (120ml) was added, followed by 37% w/w hydrochloric acid (3.87ml). After washing with water the MTBE solution of the product was set to distillation and the solvent exchanged by acetonitrile. Tert-butylamine was added at 300C. The solution was then heated to 45°C and seeded with finely ground product. After holding for 5 hours the batch was cooled to 22°C. The s resultant slurry was filtered, washed with acetonitrile and dried at 4O0C to give an off- white solid. The crude product was recrystallised from isopropanol with seeding to give 2- ({[4-(2-{ethyl[4-(trifluoromethyl)benzyl]amino}-2-oxoethyl)phenyl]thio}methyl)benzoic acid 2-methylpropan-2-amine salt (1:1). Melting point onset (DSC) is 1360C. The process to prepare this compound forms part of the present invention that is a process wherein the Q compound of formula VA is reacted with 2-methylpropan-2-amine in an inert solvent at a temperature in the range of 00C to 1000C to give 2-({[4-(2-{ethyl[4- (trifluoromethyl)benzyl]amino}-2-oxoethyl)phenyl]thio}methyl)benzoic acid 2- methylpropan-2-amine salt (1:1) . 1H NMR (DMSO) 5 7.728-7.708 d (I=I), 7.678-7.6361 (1=2), 7.425-7.405 d (1=2), 7.286 - 7.265 d (I=I), 7.241- 7.114 m (1=5), 7.0878-7.067 d (I=I), 4.709-4.695 s (1=2) (rotamers), 4.585 s (1=2) rotamers, 3.747 - 3.604 s (1=2) rotamers, 3.373 - 3.244 s (1=2) rotamers, 1.242 s (1=9), 1.082 - 0.970 t (1=3) rotamers 13C NMR (DMSO) Q 171.15, 170.34, 143.41, 143.0, 140.0, 135.92, 135.4, 132.98, 129.57, 129.52, 129.46, 129.32, 127.98, 127.88, 127.78, 127.63, 127.33, 126.19, 125.42, 125.18, 125.14, 123.0, 50.05, 47.15, 42.2, 40.5, 34.97, 28.5, 13.8, 12.47.
Preparation of Starting Material
Ethylamine hydrochloride ( 42.8g,1.23 equivalents), 4-trifluoromethyl benzaldehyde ( 75.3g, 1.00 equivalent) and toluene (188.4mL,2.55 volumes) were stirred and 4M sodium hydroxide solution (129.8 mL,1.23 equivalents) was added over 30 minutes to liberate the ethylamine. The mixture was held at ambient temperature until the reaction to the imine was complete. The biphasic liquor was separated. Water (18.2 mL) was added to the toluene phase and this imine liquor was hydrogenated with 5% Palladium on carbon (73.8mg -weight of palladium employed) as catalyst under a head of hydrogen of 200 kpascals (1 BarG) . The hydrogenated liquor was screened to remove catalyst, separated, washed with water and evaporated to give N-ethyl-4-trifluoromethylbenzylamine.
Claims
1. A process for the preparation of a compound of formula I
I in which Y is absent or represents methylene, and X is O or S which comprises reacting a compound of formula II
with a compound of formula III
in which Y is absent or represents methylene and X is O or S or a salt thereof optionally in the presence of a base and optionally in the presence of an inert solvent, at a temperature in the range of O to 1500C.
2. A process for the preparation of a compound of formula IA 
IA which comprises reacting a compound of formula II
with a compound of formula IIIA
or a salt thereof optionally in the presence of a base, optionally in the presence of an inert solvent at a temperature in the range of 0 to 150°C.
3. A process for the preparation of a compound of formula V
I wherein Y is absent or represents methylene and X is O or S with a compound of formula IV
IV wherein n is 0, 1 or 2 and R1 represents halo, a C1-4alkyl group which is optionally substituted by one or more fluoro, a Ci^alkoxy group which is optionally substituted by one or more fluoro and wherein when n is 2 the substituents R1 may be the same or different, R2 represents a C2-8alkyl group which is optionally interrupted by oxygen, optionally in the presence of a coupling agent and optionally in the presence of solvent at a temperature in the range of -100°C to 1500C.
4. A process for the preparation of a compound of formula VA
VA
which comprises reacting a compound of formula I A
IA with a compound of formula IVA
IVA
optionally in the presence of a coupling agent and optionally in the presence of solvent at a temperature in the range of 0 to 15O0C.
5. A process for the preparation of a compound of formula V 
v wherein n is 0, 1 or 2 and R1 represents halo, a Ci^alkyl group which is optionally substituted by one or more fluoro, a Ci^alkoxy group which is optionally substituted by one or more fluoro and wherein when n is 2 the substituents R1 may be the same or different, R2 represents a C2-8alkyl group which is optionally interrupted by oxygen,
Y is absent or represents methylene and X is O or S , which comprises a) reacting a compound of formula II
with a compound of formula III
III wherein Y is absent or represents methylene and X is O or S or a salt thereof optionally in the presence of a base and optionally in the presence of solvent at a temperature in the range of 0 to 15O0C to give a compound of formula I 
wherein Y is absent or represents methylene and X is O or S and then
b) reacting the compound of formula I with a compound of formula IV
IV wherein n is 0, 1 or 2 and R1 represents halo, a C1-4alkyl group which is optionally substituted by one or more fluoro, a C1-4alkoxy group which is optionally substituted by one or more fluoro and wherein when n is 2 the substituents R1 may be the same or different, R2 represents a C2-8alkyl group which is optionally interrupted by oxygen, wherein n is 0, 1 or 2 and R1 represents halo, a C1-4alkyl group which is optionally substituted by one or more fluoro, a Q^alkoxy group which is optionally substituted by one or more fluoro and wherein when n is 2 the substituents R1 may be the same or different, R2 represents a C2-galkyl group which is optionally interrupted by oxygen, optionally in the presence of a coupling agent and optionally in the presence of solvent, at a temperature in the range of 0 to 15O0C .
6. A process for the preparation of a compound of formula VA
with a compound of formula IIIA
IIIA
or a salt thereof optionally in the presence of a base and optionally in the presence of solvent at a temperature in the range of 0 to 150°C to give a compound of formula IA
IA and then
b) reacting the compound of formula IA with a compound of formula IVA
IVA optionally in the presence of a coupling agent and optionally in the presence of solvent at a temperature in the range of 0 to 1500C .
7. A process according to claim 6 wherein the compound of formula VA is reacted with 2-methylpropan-2-amine in an inert solvent at a temperature in the range of O0C to 1000C to give 2-({[4-(2-{ethyl[4-(trifluoromethyl)benzyl]amino}-2- oxoethyl)phenyl]thio}methyl)benzoic acid 2-methylpropan-2-amine salt (1:1) .
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0522431A GB0522431D0 (en) | 2005-11-03 | 2005-11-03 | Chemical process |
| GB0522431.6 | 2005-11-03 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2007052001A2 true WO2007052001A2 (en) | 2007-05-10 |
| WO2007052001A3 WO2007052001A3 (en) | 2007-07-12 |
Family
ID=35516262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/GB2006/004044 Ceased WO2007052001A2 (en) | 2005-11-03 | 2006-10-31 | Production process of ortho-substituted benzoic acid derivatives usin 4-(2-carboxybenzyloxy or thio)-phenylacetic acid as key intermediate |
Country Status (3)
| Country | Link |
|---|---|
| GB (1) | GB0522431D0 (en) |
| TW (1) | TW200800859A (en) |
| WO (1) | WO2007052001A2 (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK467274A (en) * | 1973-09-13 | 1975-05-12 | Sandoz Ag | |
| US4526891A (en) * | 1983-03-10 | 1985-07-02 | Hoechst Roussel Pharmaceuticals Inc. | Substituted alkyl amine derivatives of 6,11-dihydro-11-oxodibenz[b,e]oxepins |
| JP3272819B2 (en) * | 1993-06-16 | 2002-04-08 | 協和醗酵工業株式会社 | Method for producing benzoic acid and nicotinic acid derivatives |
| DE60319084T2 (en) * | 2002-06-20 | 2009-01-29 | Astrazeneca Ab | ORTHO-SUBSTITUTED BENZOIC ACID DERIVATIVES FOR THE TREATMENT OF INSULIN RESISTANCE |
-
2005
- 2005-11-03 GB GB0522431A patent/GB0522431D0/en not_active Ceased
-
2006
- 2006-10-31 WO PCT/GB2006/004044 patent/WO2007052001A2/en not_active Ceased
- 2006-11-02 TW TW95140586A patent/TW200800859A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW200800859A (en) | 2008-01-01 |
| GB0522431D0 (en) | 2005-12-14 |
| WO2007052001A3 (en) | 2007-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6181168B2 (en) | Process for the preparation of certain 2- (pyridin-3-yl) thiazoles | |
| EP3812366B1 (en) | A preparation method for m-diamide compounds | |
| CN107365275B (en) | High purity celecoxib | |
| WO2014020555A2 (en) | An improved process for the preparation of dabigatran etexilate mesylate | |
| KR20150100809A (en) | Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1H-pyrazol-3-ylamine | |
| WO2003076374A1 (en) | PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE | |
| JP4647783B2 (en) | Chemical synthesis of morpholine derivatives | |
| WO2008090046A1 (en) | Alternate process for preparing 3,5-di-omicron-acyl-2-fluoro-2-c-methyl-d-ribono-gamma-lactone | |
| CN102532109B (en) | Synthetic method of lapatinib and salt of lapatinib | |
| US6657085B2 (en) | Process for the preparation of aniline compounds | |
| AU2001267442A1 (en) | Process for the preparation of aniline compounds | |
| CN112272665A (en) | Process for preparing sitagliptin | |
| EP2982673B1 (en) | Process for manufacturing 5-chloromethyl-2,3-dicarboxylic anhydride | |
| WO2015018289A1 (en) | Novel method for synthesizing key intermediate of apixaban | |
| JP4908706B2 (en) | Benzofuran derivatives | |
| WO2007052001A2 (en) | Production process of ortho-substituted benzoic acid derivatives usin 4-(2-carboxybenzyloxy or thio)-phenylacetic acid as key intermediate | |
| US8815870B2 (en) | 4-(2-(6-substituted-hexylidene) hydrazinyl)benzonitrile and preparation thereof | |
| CN104610133A (en) | Method for synthesizing novel anticancer medicine entinostat | |
| JP5507579B2 (en) | Process for the preparation of N- [5- (3-dimethylamino-acryloyl) -2-fluoro-phenyl] -N-methyl-acetamide | |
| WO2008075380A2 (en) | Process for the preparation of thiazolidine derivatives | |
| KR20200088570A (en) | Process for Preparation of Fimasartan and Intermediate for Preparing the Same | |
| WO2007111024A1 (en) | Process for production of ethylenediamine derivative having halogenated carbamate group and acyl group, and intermediated for production of the derivative | |
| JP4398636B2 (en) | Process for producing N- [3- (acylamino) -4-oxo-6-phenoxy-4H-chromen-7-yl] alkylsulfonamide derivatives or salts thereof and intermediates thereof | |
| CN119431209A (en) | A preparation method and application of a key intermediate of Vibelon | |
| JP5142241B2 (en) | Method for producing nicotinic acid ester compound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 06794945 Country of ref document: EP Kind code of ref document: A2 |